A Major Shareholder at Synthetic Biologics Inc (SYN) is Selling Shares


Today, a Major Shareholder at Synthetic Biologics Inc (SYN), Randal Kirk, sold shares of SYN for $98.84K.

This is Kirk’s first Sell trade following 3 Buy transactions.

See today’s analyst top recommended stocks >>

Currently, Synthetic Biologics Inc has an average volume of 284K.

Randal Kirk’s trades have generated a -9.5% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Synthetic Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. Its product portfolio includes SYN-010 and SYN-004.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts